Abstract:FKBP51 is well-known as a cochaperone of Hsp90 machinery and implicated in many human diseases including stress-related diseases, tau-mediated neurodegeneration and cancers, which makes FKBP51 an attractive drug target for the therapy of FKBP51-associated diseases. However, it has been reported that only nature product rapamycin, cyclosporine A, FK506 and its derivatives exhibit good binding affinities when bound to FKBP51 by now. Given the advantages of peptide-inhibitors, we designed and obtained 20 peptide-inhibitor hits through structure-based drug design. We further characterized the interaction modes of the peptide-inhibitor hits on the FK1 domain of FKBP51 by biochemical and structural biology methods. Structural analysis revealed that peptide-inhibitor hits form U-shaped conformations and occupy the FK506 binding pocket and share similar interaction modes with FK506. Using molecular dynamics simulations, we delved into the interaction dynamics and found that hits are anchored to the FK506 binding pocket in a quite stable conformation. Meanwhile, it was shown that interactions between FK1 and peptide-inhibitor hits are mainly attributed to the hydrogen bond networks comprising I87 and Y113 and FPF cores of peptide-inhibitors involved extensive hydrophobic interactions. We presumed that the peptide design strategy based on the small molecule structure probably shed new lights on the peptide-inhibitor discovery of other targets. The findings presented here could also serve as a structural basis and starting point facilitating the optimization and generation of FKBP51 peptide-inhibitors with better bio-activities.Peptide-inhibitor hits were designed with small molecules published before used as the starting point through structure-based drug design and biochemically andstructurally characterized the interaction modes between the FK1 domain of FKBP51 and hitsDownload : Download high-res image (86KB)Download : Download full-size image

Binding Modes and Conformational Changes of FK506-binding Protein 51 Induced by Inhibitor Bindings: Insight into Molecular Mechanisms Based on Multiple Simulation Technologies

Molecular Dynamics Simulation, Binding Free Energy Calculation and Unbinding Pathway Analysis on Selectivity Difference Between FKBP51 and FKBP52: Insight into the Molecular Mechanism of Isoform Selectivity

Potential inhibitors for FKBP51: an in silico study using virtual screening, molecular docking and molecular dynamics simulation

A Computational Analysis of the Binding Affinities of FKBP12 Inhibitors Using the MM‐PB/SA Method

Exploring the Binding Mechanism Between Human Profilin (PFN1) and Polyproline-10 Through Binding Mode Screening

Dynamics Revelation of Conformational Changes and Binding Modes of Heat Shock Protein 90 Induced by Inhibitor Associations

A Computational Insight into Binding Modes of Inhibitors XD29, XD35, and XD28 to Bromodomain-Containing Protein 4 Based on Molecular Dynamics Simulations.

Molecular Mechanism Concerning Conformational Changes of CDK2 Mediated by Binding of Inhibitors Using Molecular Dynamics Simulations and Principal Component Analysis

Discovery of pentapeptide-inhibitor hits targeting FKBP51 by combining computational modeling and X-ray crystallography

Multi-Scaled Explorations of Binding-Induced Folding of Intrinsically Disordered Protein Inhibitor IA3 to Its Target Enzyme

Free Energy Profile and Kinetics of Coupled Folding and Binding of the Intrinsically Disordered Protein p53 with MDM2

Combined x-ray crystallography and computational modeling approach to investigate the Hsp90 C-terminal peptide binding to FKBP51

Decoding molecular mechanism of inhibitor bindings to CDK2 using molecular dynamics simulations and binding free energy calculations

Exploring the interaction between human focal adhesion kinase and inhibitors: a molecular dynamic simulation and free energy calculations

Molecular Dynamics Exploration of Selectivity of Dual Inhibitors 5M7, 65X, and 65Z Toward Fatty Acid Binding Proteins 4 and 5.

Binding Mechanism of Inhibitors to P38α MAP Kinase Deciphered by Using Multiple Replica Gaussian Accelerated Molecular Dynamics and Calculations of Binding Free Energies.

Decoding the Conformational Selective Mechanism of FGFR Isoforms: A Comparative Molecular Dynamics Simulation

Molecular Mechanism with Regard to the Binding Selectivity of Inhibitors Toward FABP5 and FABP7 Explored by Multiple Short Molecular Dynamics Simulations and Free Energy Analyses

Revealing The Binding Modes And The Unbinding Of 14-3-3 Sigma Proteins And Inhibitors By Computational Methods

Theoretical Exploration of the Binding Selectivity of Inhibitors to BRD7 and BRD9 with Multiple Short Molecular Dynamics Simulations

Molecular Dynamics Simulation Framework to Probe the Binding Hypothesis of CYP3A4 Inhibitors